CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,431 enrolled
Drug / intervention
Patient Activation +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03171545
NCT03171545N/ACompleted
CompareCT.gov

Enhancing the Cardiovascular Safety of Hemodialysis Care: A Cluster-Randomized, Comparative Effectiveness Trial of Multimodal Provider Education and Patient Activation Interventions (Dialysafe)

University of Michigan·interventional·Posted May 31, 2017·Updated Jan 14, 2026

In Brief

A clinical study evaluating Patient Activation and Provider Education for Kidney Failure and 4 related conditions. Completed, enrolled 1,431 participants across 1 site.

Detailed Summary

The purpose of this study is reduce episodes of intradialytic hypotension, low blood pressure during a hemodialysis session, in patients with End Stage Renal Disease (ESRD). Recruitment will take place on the clinic level rather than the patient level.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Failure, End Stage Renal Disease, Hypotension, Cardiovascular Diseases, Patient Safety
CountriesUnited States
CollaboratorsUniversity of California, Irvine, National Kidney Foundation, United States, Fresenius Medical Care North America

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 31, 2017
Enrollment StartJan 11, 2023
Primary CompletionNov 17, 2024
Study CompletionDec 13, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.1 years ago

Interventions

Patient Activationbehavioral

Patients in clinics assigned to this group will be offered peer mentoring and digital resources.

Provider Educationbehavioral

Staff in clinics assigned to this group will receive team training and a checklist.